Systemic Hypertension · 2021 · 11 citations · 153 references
MedicineCardiologyPharmacotherapyCardiovascular PharmacotherapyClinical CardiologyElectrophysiologyAntiarrhythmic TherapyAtrial FibrillationCardiac ArrhythmiasCardiovascular DiseaseCardiovascular PathophysiologyCardiovascular RiskAtrial Arrhythmia MechanismsAtrial Fibrillation In HypertensionAtrial Fibrillation PathophysiologyAtrial Fibrillation Risk AssessmentCardiomyocyte EnergeticsCardiovascular Disease ManagementCardiovascular Disease PrevalenceHypertension-related Cardiac Risk
Arterial hypertension (AH) is a leading risk factor for cardiovascular disease as well as it is the most common, independent and potentially reversible risk factor for atrial fibrillation (AF). AH contributes to the occurrence and maintenance of AF due to hemodynamic disorders, alterations in cardiomyocyte electrophysiological properties and structural remodeling in the atria. AF, which is also associated with an increased risk of cardiovascular events, is the most common arrhythmia. AH and AF often coexist, and their prevalence increases with age. This consensus provides the key features of the management of patients with these nosological units. The pathogenesis, risk stratification, and features of the selection of antihypertensive, antiarrhythmic and antithrombotic therapy are described in detail.
153
A New Equation to Estimate Glomerular Filtration Rate
Andrew S. Levey, Lesley A. Stevens, Christopher H. Schmid et al. · Annals of Internal Medicine · 2009 · 25.7K citations
Pharmacy, Nephrology, Physiology +12
2018 ESC/ESH Guidelines for the management of arterial hypertension
Bryan Williams, Giuseppe Mancia, Wilko Spiering et al. · European Heart Journal · 2018 · 10.4K citations · Full text
Gerhard Hindricks, Tatjana Potpara, Nikolaos Dagres et al. · European Heart Journal · 2020 · 9.9K citations · Full text
Global burden of hypertension: analysis of worldwide data
Patricia M. Kearney, Megan Whelton, Kristi Reynolds et al. · The Lancet · 2005 · 7.7K citations